US › Healthcare

cbdMD Inc (YCBD)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.50+7.30%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$5.6M

Revenue YoY

+20.6%

Net profit

$-1.1M

EPS

$-0.11

EPS estimate

$-0.03

Net margin

-20.3%

EPS came in at -0.11 against a street estimate of -0.03 — a miss of 266.7%.

Key statistics

Market cap

$5.2M

P/E

2.0

Forward P/E

714.3

P/B

0.63

Book value

$0.77

EPS (TTM)

$0.23

52-week high

$2.56

52-week low

$0.45

50-day MA

$0.55

200-day MA

$0.78

Beta

2.17

Analyst view

Analysts rate cbdMD Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

10.00%

Institutions

8.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for cbdMD Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.